From constant control to everyday freedom: MiniMed™ 780G
Who and why is the MiniMed™ 780G insulin pump effective?
An insulin pump is an investment for any diabetic patient who requires frequent injections and whose glucose readings are outside the target range. The pump can deliver insulin doses as low as 0.025 DV, which means less risk of hypoglycemia, not to mention manual calculations for adjustments. The pump uses the sensor readings to calculate whether and how much additional insulin is needed in a closed loop.
- For people with type 1 diabetes because their body does not produce insulin itself and glucose levels can fluctuate rapidly.
- Children and adolescents who have irregular daily routines (eating, physical activity) have difficulty calculating the required insulin dose. It is essential to improve the quality of life for both the child or adolescent and their family.
- Patients with frequent hypoglycemia , especially at night.
- For active people whose physical activity changes require flexible and rapid insulin adjustments.
- For users who have difficulty achieving stable blood sugar levels with injections or who often forget to boluses.
Why is the MiniMed™ 780G one of the best systems in the world?
It demonstrates the highest Time in Range (TIR) rate among all automated insulin delivery systems.
Thanks to the system's accuracy, safety, efficiency, and stability, more than 100,000 users worldwide have already chosen the MiniMed™ 780G.
The pump is used with the Guardian 4 sensor, it is factory calibrated, there is no need for a mandatory finger prick. The system is able to recognize the impact of meals and automatically adjusts and corrects sugar levels every five minutes.
MiniMed ™ 780G technological superiority
The main advantage and superiority of the MiniMed™ 780G is its algorithm, which can currently be considered the smartest compared to other solutions.
- Lower target glucose levels - the system allows you to safely set a target of up to 100 mg/dl, while most other solutions, such as the Omnipod 5, only allow up to 110 mg/dl. This means more precise control and the ability to get closer to optimal results.
- Frequent correction doses - The MiniMed™ 780G can make corrections every 5 minutes if glucose levels start to rise. Most alternatives can only do this once an hour, which means a significantly slower response.
- Fast and customized response to glucose spikes - the algorithm accurately calculates and delivers exactly the amount of insulin needed at a given moment, ensuring timely and effective stabilization of glucose control.
Results of a study comparing the world's most well-known systems
A study published in Diabetes Technology & Therapeutics compared the most commonly used automated insulin delivery systems in the world. The metric diabetes professionals compared in this study was Time in Range (TIR). The MiniMed™ 780G demonstrated superiority over other similar systems.
What does the graph reveal?
The graph shows that MiniMed™ 780G users spend the most time in their target range during the day compared to other systems, more than 75% of the time in their target glucose levels, and even more than 80% under optimal conditions. In other words, the 780G helps keep blood sugar levels more stable. This means that users spend about 19 hours a day in the safe, healthy range (70 /180 mg/dL, or 3.9 /10.0 mmol/L).
This result is associated with a lower risk of hypoglycemia, better well-being, and in the long term, a lower likelihood of diabetes complications, thus improving quality of life and survival.
Promising efficacy of the MiniMed™ 780G system in pregnant women with type 1 diabetes
During pregnancy, blood sugar fluctuations become more pronounced because insulin needs can change very rapidly. This makes controlling diabetes during pregnancy particularly difficult, as the expectant mother must be able to protect both herself and her baby from blood sugar levels that are too high or too low.
Studies show that the MiniMed™ 780G can improve nighttime glycemic stability, reduce the frequency of hypoglycemic episodes, reduce weight gain during pregnancy, and improve a woman's overall well-being.
Summary
Taking into account the above, we can conclude that with the MiniMed™ 780G, pregnant women have reduced the frequency of nocturnal hypoglycemia, reduced weight gain and improved the overall well-being of the woman. Lower risk of hypoglycemia for everyone, better well-being and in the long term lower risk of diabetes complications and thus also improved quality of life and survival for every user.
Want to know more?
If you are considering improving your diabetes control with modern technology or would like to learn more about how the MiniMed™ 780G can help you or your loved one, you can always contact us for more information.
View the MiniMed™ 780G insulin pump in our online store.
If you have any questions or need advice, ask our specialists at +371 29611419.



